List of Desyrel drug patents
Desyrel is owned by Pragma.
Desyrel contains Trazodone Hydrochloride.
Desyrel has a total of 1 drug patent out of which 0 drug patents have expired.
Desyrel was authorised for market use on 25 March, 1985.
Desyrel is available in tablet;oral dosage forms.
The generics of Desyrel are possible to be released after 13 March, 2029.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US8133893 | PRAGMA | Trazodone and trazodone hydrochloride in purified form |
Mar, 2029
(6 years from now) | |
Drugs and Companies using TRAZODONE HYDROCHLORIDE ingredient
Market Authorisation Date: 25 March, 1985
Treatment: NA
Dosage: TABLET;ORAL
How can I launch a generic of DESYREL before it's patent expiration?
More Information on Dosage
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic